A randomized controlled study of vitrectomy combined with recombinant tissue-type fibrinogen activator submacular injection for the treatment of polypoid choroidal vasculopathy complicated with massive submacular hemorrhage.
Minerva Med
; 114(4): 573-575, 2023 08.
Article
in En
| MEDLINE
| ID: mdl-35766550
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vitrectomy
/
Hemorrhage
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
Minerva Med
Year:
2023
Document type:
Article
Affiliation country:
China